Delivery Order SPE2DE24D0021-SPE2D625F2LLN
- Not listed
- Fisher Scientific Company L.L.C. was awarded a $3,099.96 fixed-price delivery order with economic price adjustment on August 11, 2025, to supply PROFILE-V 12 Panel DOA (Drugs of Abuse) Test kits at 25 per package. The contract, which is a child order under a larger vehicle, will be performed in Pittsburgh, Pennsylvania, with an ultimate completion date of August 25, 2025. No set-aside designation was used in this award. The funding source is identified as the Medical Supply Chain within the...
- Fisher Scientific Company L.L.C. has been awarded a delivery order contract valued at $8,266.56 for the procurement of PROFILE-V 12 Panel DOA (Drugs of Abuse) Test kits, 25 per pack, on July 24, 2025. The contract carries a fixed-price structure with economic price adjustment provisions and is scheduled for completion by July 31, 2025. This is an uncompensated delivery order with no set-aside designation, reflecting Fisher Scientific's competitive standing in open federal procurement. The...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $6,199.92 on July 21, 2025, for the procurement of Profile-V 12 Panel DOA (Drugs of Abuse) Test kits, 25 per pack (Contract Number 4568847894). The contract is fixed price with economic price adjustment provisions and carries an ultimate completion date of July 28, 2025. Performance will occur in Pittsburgh, Pennsylvania, and the award was made without a set-aside designation, indicating open competition. The funding federal...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $1,722.20 by the Defense Medical Supply Chain federal agency for the procurement of PROFILE-V 12 Panel DOA (Drugs of Abuse) Test kits, 25 per pack. This fixed-price delivery order with economic price adjustment was awarded on July 18, 2025, with an ultimate completion date of July 25, 2025, and will be performed in Pittsburgh, Pennsylvania. The award represents a child contract, indicating it falls under a larger...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,722.20 on August 22, 2025, for the supply of Profile-V 12-panel DOA (drugs of abuse) test kits, 25 per pack, under a fixed-price contract with economic price adjustment. The contract is set to be completed by August 29, 2025, and performance will take place in Pittsburgh, Pennsylvania. This award was issued by the Defense or Civilian Medical Supply Chain federal agency as part of a child contract with no set-aside...
- Fisher Scientific Company L.L.C. was awarded a $3,444.40 delivery order contract by the Department of Defense's Medical Supply Chain on July 22, 2025, for the procurement of an analytical profile kit for MedToxScan human urine testing. The contract, which is classified as a child award with no set-aside designation, is structured as a fixed-price delivery order with economic price adjustment provisions and will be performed in Pittsburgh, Pennsylvania. This award represents a continuation of...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,200 on August 4, 2025, by the Defense Medical Supply Chain to provide toxicology and drugs of abuse control reagents and supplies. This fixed-price contract with economic price adjustment carries an ultimate completion date of August 18, 2025, and will be performed in Pittsburgh, PA. The award represents a child contract under a larger vehicle structure and was made through open competition with no set-aside...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $3,444.40 to Fisher Scientific Company L.L.C. on July 23, 2025, for the procurement of analytical profile kits for medical toxicology scanning of human urine samples. This fixed-price delivery order, with economic price adjustment provisions, represents a child contract with an ultimate completion date of July 29, 2025, and will be performed in Pittsburgh, Pennsylvania. The award was made through open...
- Fisher Scientific Company L.L.C. was awarded a delivery order on July 25, 2025, valued at $1,135.57 under a fixed-price contract with economic price adjustment provisions. The contract, which carries no set-aside designation, is for the delivery of an immunoassay kit with rapid analysis capabilities to support medical supply chain operations within the Department of Defense. Performance will be completed in Pittsburgh, Pennsylvania, with an ultimate completion date of July 31, 2025. This...
- Fisher Scientific Company L.L.C., a major federal supplier of laboratory supplies and scientific equipment, was awarded a delivery order valued at $4,430.32 by the Department of Defense's Medical Supply Chain agency on August 8, 2025. This fixed-price delivery order with economic price adjustment clause is classified as a child contract, indicating it derives from a larger procurement vehicle. The order is scheduled for completion by August 22, 2025, with performance taking place at Fisher...
- SPE2DE24D0021Indefinite Delivery Contract
- SPE2DE24D0021-SPE2D625F2LLNDelivery Order
Fisher Scientific Company L.L.C. was awarded a delivery order valued at $2,555.76 for the procurement of a PROFILE-V 11PNL DOA TEST 25/PK (a drug of abuse screening test product) on September 3, 2025. This fixed-price delivery order with economic price adjustment has an ultimate completion date of September 10, 2025 and will be performed in Pittsburgh, Pennsylvania. The contract was awarded without a set-aside designation, indicating open competition. The funding source is the Medical Supply Chain within the Defense agency, reflecting the Department of Defense's need for specialized laboratory testing supplies to support its medical and diagnostic operations. This delivery order represents a child contract under a larger vehicle arrangement and aligns with Fisher Scientific's established role as a critical federal supplier of laboratory and medical testing products. The company, registered in SAM.gov since 2001, maintains extensive experience providing diagnostic reagents and testing solutions to defense and civilian agencies. The specific procurement of drug of abuse screening tests supports the Defense agency's occupational health and safety compliance programs, which require regular substance screening capabilities across military and defense installations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 9/3/25 |